Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hisashi Shinkai. (2012) Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases. Vascular Health and Risk Management 8, pages 323-331.
Read now
Read now
Jennifer G Robinson. (2010) Dalcetrapib: a review of Phase II data. Expert Opinion on Investigational Drugs 19:6, pages 795-805.
Read now
Read now
Articles from other publishers (12)
Christel A.S. Bergström, William N. Charman & Christopher J.H. Porter. (2016) Computational prediction of formulation strategies for beyond-rule-of-5 compounds. Advanced Drug Delivery Reviews 101, pages 6-21.
Crossref
Crossref
Eric J. Niesor, Andrea Greiter-Wilke & Lutz Müller. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety
435
456
.
Maria Drakopoulou, Konstantinos Toutouzas & Christodoulos Stefanadis. (2013) Novel pharmacotherapies of familial hyperlipidemia. Pharmacology & Therapeutics 139:3, pages 301-312.
Crossref
Crossref
Lalgudi S. Harikrishnan, Heather J. Finlay, Jennifer X. Qiao, Muthoni G. Kamau, Ji Jiang, Tammy C. Wang, James Li, Christopher B. Cooper, Michael A. Poss, Leonard P. Adam, David S. Taylor, Alice Ye A. Chen, Xiaohong Yin, Paul G. Sleph, Richard Z. Yang, Doree F. Sitkoff, Michael A. Galella, David S. Nirschl, Katy Van Kirk, Arthur V. Miller, Christine S. Huang, Ming Chang, Xue-Qing Chen, Mark E. Salvati, Ruth R. Wexler & R. Michael Lawrence. (2012) Diphenylpyridylethanamine (DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors. Journal of Medicinal Chemistry 55:13, pages 6162-6175.
Crossref
Crossref
David RhaindsBenoit J ArsenaultMathieu R BrodeurJean-Claude Tardif. (2012) An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels. Future Cardiology 8:4, pages 513-531.
Crossref
Crossref
Ana Escribano, Ana I. Mateo, Eva M. Martin de la Nava, Daniel R. Mayhugh, Sandra L. Cockerham, Thomas P. Beyer, Robert J. Schmidt, Guoqing Cao, Youyan Zhang, Timothy M. Jones, Anthony G. Borel, Stephanie A. Sweetana, Ellen A. Cannady & Nathan B. Mantlo. (2012) Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors. Bioorganic & Medicinal Chemistry Letters 22:11, pages 3671-3675.
Crossref
Crossref
Jes?s Mill?n N??ez-Cort?s, Eduardo Alegr?a, Luis Alvarez-Sala Walther, Juan Ascaso Gimilio, Carlos Lahoz Rallo, Teresa Mantilla Morat?Jos? M. Mostaza Prieto, Juan Pedro-Botet Montoya & Xavier Pint? Sala. (2012) Documento Abordaje de la dislipidemia. Sociedad Espa?ola de Arteriosclerosis (parte III). Cl?nica e Investigaci?n en Arteriosclerosis 24:2, pages 102-107.
Crossref
Crossref
Nicholas A. Meanwell. (2011) Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety. Chemical Research in Toxicology 24:9, pages 1420-1456.
Crossref
Crossref
Avishay Elis, David Pereg, Paul Froom, Michael Lishner, David Segev & Doron Hermoni. (2011) HDL‐C Levels and Revascularization Procedures in Coronary Heart Disease Patients Treated With Statins to Target LDL‐C Levels. Clinical Cardiology 34:9, pages 572-576.
Crossref
Crossref
Alexandros Vakalopoulos, Carsten Schmeck, Michael Thutewohl, Volkhart Li, Hilmar Bischoff, Klemens Lustig, Olaf Weber, Holger Paulsen & Harry Elias. (2011) Chromanol derivatives—A novel class of CETP inhibitors. Bioorganic & Medicinal Chemistry Letters 21:1, pages 488-491.
Crossref
Crossref
Eric J. Niesor, Christine Magg, Naoto Ogawa, Hiroshi Okamoto, Elisabeth von der Mark, Hugues Matile, Georg Schmid, Roger G. Clerc, Evelyne Chaput, Denise Blum-Kaelin, Walter Huber, Ralf Thoma, Philippe Pflieger, Makoto Kakutani, Daisuke Takahashi, Gregor Dernick & Cyrille Maugeais. (2010) Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport. Journal of Lipid Research 51:12, pages 3443-3454.
Crossref
Crossref
Bi‐lian Yu, Shu‐hui Wang, Dao‐quan Peng & Shui‐ping Zhao. (2010) HDL and immunomodulation: an emerging role of HDL against atherosclerosis. Immunology & Cell Biology 88:3, pages 285-290.
Crossref
Crossref